The company had posted a net profit of Rs 37.36 crore in the October-December period a year ago, according to a regulatory filing from Bajaj Electricals
Fintech firm to discontinue small-ticket lending product and focus on long-tenure products
Asian Paints Q3 FY25 results: Sequentially, profit rose 60% from ₹694.64 crore.
Q3FY25 company results today, February 4: Godrej Properties, Whirlpool of India, Happiest Minds Technologies, Hikal, and Infibeam Avenues will release their reports for the Oct-Dec 2024 quarter
Total income stood at Rs 960.76 crore during the April-September period of the current 2024-25 financial year, according to the company's Draft Red Herring Prospectus (DRHP) filed with Sebi last week
Infrastructure developer Welspun Enterprises on Monday reported a 4 per cent fall in its consolidated profit after tax to Rs 77 crore in the December quarter.
Consolidated income from operations during the quarter under review stood at Rs 2,061.01 crore as compared to Rs 1,893.13 crore in the year-ago period, it added
HFCL managing director, Mahendra Nahata said that despite a dynamic and challenging market environment, HFCL has demonstrated resilience with a stable quarterly performance
The state-run energy transmission company's consolidated net profit fell 4% to 38.62 billion rupees ($443.5 million) in the three months to Dec. 31
Quarterly revenue grew 7.1 per cent to 13.54 billion rupees in the October to December quarter due to higher sales of its lubricants for two-wheelers and commercial vehicles
Alembic's revenue from operations rose to Rs 1,692.74 crore in Q3FY25, a 3.8 per cent Y-o-Y increase from Rs 1,630.57 crore in Q3FY24
Tata Chemicals said it incurred a non-cash writedown on assets aggregating to 700 million rupees with respect to its UK operations
Rivals Sun Pharma and Cipla beat third-quarter profit estimates, while Dr Reddy's missed expectations. All three drugmakers saw muted growth in the North American market, including the US
The company had posted a loss after tax of Rs 0.82 crore in the October-December period a year ago, according to a regulatory filing by HMVL, the publisher of Hindi daily Hindustan
A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North American market has weighed on domestic firms' margins
Its revenue from operations climbed 25 per cent to Rs 2,319 crore during the quarter, roughly in line with analysts' estimate of Rs 2,343 crore
The company's total revenue from operations also surged 47.9 per cent to Rs 1,326 crore in the reporting quarter from Rs 896 crore a year ago
For the first 10 months of the current fiscal (April 2024-January 2025), CIL's offtake reached 630.2 MT, reflecting a 1.8 per cent increase, from 619.4 MT in the corresponding period last year
Total income declined to Rs 1,256.63 crore in the October-December quarter against Rs 2,213.68 crore in the year-ago period
During the quarter, the metals and oil & gas company reported a consolidated net profit of Rs 3,547 crore, compared to Rs 2,013 crore a year ago